Physician profile
Joy A Bate
NPI 1275536518
$4,199.04
in general payments reported to CMS, 2019-2025
15 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $98.09 · 2021: $418 · 2022: $1,051 · 2023: $272 · 2024: $1,819 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.73 |
| Travel and Lodging | $1,057.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,173.15 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $664.62 | 2021-2022 | |
| Coopervision INC. | $611.80 | 2021-2025 | Myday Contact Lens, Misight Contact Lens |
| Allergan, INC. | $184.85 | 2019-2021 | |
| Glaukos Corporation | $126.68 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $121.84 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $75.06 | 2025 | Contact Lens, Spectacle Lenses |
| Tearlab Corp | $46.30 | 2021-2022 | |
| Biotissue Holdings INC. | $42.44 | 2022 | |
| Oyster Point Pharma, INC. | $40.88 | 2022-2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $37.04 | 2020-2022 | |
| Shire North American Group INC | $23.58 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $15.93 | 2024 | Xiidra, Miebo |
| Abbvie INC. | $15.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Bate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.